Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer's Disease than Amyloid or Tau

J Cell Immunol. 2022;4(1):15-18.

Authors

Tyler C Hammond^{1

2}, Ai-Ling Lin^{1

3

4}

Affiliations

¹ Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
² Department of Neuroscience, University of Kentucky, Lexington, KY, USA.
³ Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
⁴ Department of Radiology and Biological Sciences, University of Missouri, Columbia, MO, USA.

PMID: 35373192
PMCID: PMC8975178

No abstract available

Publication types

Comment

Grants and funding